异吲哚啉-1-羧酸甲酯盐酸盐 | 60651-97-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 异吲哚啉-1-羧酸甲酯盐酸盐
• 英文名称: Methyl 1,3-dihydro-2H-isoindole-1-carboxylate Hydrochloride
• 英文别名: methyl isoindoline-1-carboxylate hydrochloride；2,3-dihydro-1H-isoindole-1-carboxylic acid, methyl ester, hydrochloride；methyl 2,3-dihydro-1H-isoindole-1-carboxylate;hydrochloride
• CAS: 60651-97-0
• 化学式: C₁₀H₁₁NO₂*ClH
• 分子量: 213.664
• InChiKey: DJNUAJTYYAIRRW-UHFFFAOYSA-N

物化性质

• 熔点：
  159-161 °C(Solv: ethanol (64-17-5); ethyl ether (60-29-7))

计算性质

• 辛醇/水分配系数(LogP)：
  1.43
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  异吲哚啉-1-羧酸甲酯盐酸盐 在 铑 、 甲烷 溶剂黄146 作用下， 以 甲醇 为溶剂， 生成 methyl octahydro-1H-isoindole-1-carboxylate hydrochloride
  参考文献：
  名称：

  Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids

  摘要：

  将辛烷基-1H-异吲哚-1-羧酸化合物的取代酰基衍生物及其药学上可接受的盐通过用适当取代的辛烷基-1H-异吲哚与适当活化的取代羧酸酰基化，并在需要时水解所得产物来制备。该发明的化合物、它们的盐和药物组合物可用作降压药。

  公开号：

  US04503043A1
• 作为产物：
  描述：

  2-Benzyl-2,3-dihydro-1H-isoindole-1-carboxylic acid methyl ester hydrochloride 以86%的产率得到
  参考文献：
  名称：

  CIGNARELLA G.; CERRI R.; GRELLA G.; SANNA P., GAZZ. CHIM. ITAL. , 1976, 106, NO 1-2, 65-75

  摘要：

  DOI：

文献信息

• [EN] ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS<br/>[FR] COMPOSÉS ANTIVIRAUX POUR LE TRAITEMENT D'INFECTIONS À CORONAVIRUS, PICORNAVIRUS ET NOROVIRUS
  申请人：ALIGOS THERAPEUTICS INC

  公开号：WO2021252491A1

  公开（公告）日：2021-12-16

  Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating coronavirus, Picomavirus and Norovims infections with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

  本文提供了式（I）的化合物或其药用盐，包括包含本文描述的化合物（包括本文描述的化合物的药用盐）的药物组合物以及合成这些化合物的方法。本文还提供了使用式（I）的化合物或其药用盐治疗冠状病毒、皮科病毒和诺如病毒感染的方法。
• Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis
  申请人：——

  公开号：US20030229024A1

  公开（公告）日：2003-12-11

  Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

  本发明涉及一种抑制&bgr;-淀粉样肽释放和/或合成的化合物，因此具有治疗阿尔茨海默病的用途。还公开了药物组合物，包括抑制&bgr;-淀粉样肽释放和/或合成的化合物，以及使用这样的药物组合物进行预防和治疗阿尔茨海默病的方法。
• Isoindoline derivative
  申请人：WAKUNAGA SEIYAKU KABUSHIKI KAISHA

  公开号：EP0343560A2

  公开（公告）日：1989-11-29

  1. Isoindoline derivatives represented by the formula (I) and their salts are disclosed. There are many varieties for the compound depending on the types of residues R1-R9 and X. The compounds can be prepared from quinoline derivsatives of the formula (II) and an isoindoline derivatives of the formula (III). The compounds of formula (I) and their salts have excellent antibacterial activities against both gram positive and gram negative microorganisms. They can be used as a medicine, an agrichemical, and a food preservative.

  1.本发明公开了以式（I）为代表的异吲哚啉衍生物及其盐类。 根据 R1-R9 和 X 的残基类型，该化合物有许多种类。该化合物可由式（II）的喹啉衍生物和式（III）的异吲哚啉衍生物制备。式（I）化合物及其盐类对革兰氏阳性和革兰氏阴性微生物都有很好的抗菌活性。它们可用作药物、农用化学品和食品防腐剂。
• BICYCLIC AZA COMPOUNDS AS MUSCARINIC RECEPTOR AGONISTS
  申请人：Heptares Therapeutics Limited

  公开号：EP3406609A1

  公开（公告）日：2018-11-28

  This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1b or a salt thereof, wherein Q, R3 and R4 are as defined herein.

  本发明涉及的化合物是毒蕈碱 M1 受体和/或 M4 受体的激动剂，可用于治疗毒蕈碱 M1/M4 受体介导的疾病。本发明还提供了含有这些化合物的药物组合物以及这些化合物的治疗用途。化合物包括符合式 1b 的化合物 或其盐，其中 Q、R3 和 R4 如本文所定义。
• Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
  申请人：Heptares Therapeutics Limited

  公开号：US10196380B2

  公开（公告）日：2019-02-05

  This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1, or a salt thereof, wherein Q, R1, R2, R3 and R4 are as defined herein.

  本发明涉及的化合物是毒蕈碱 M1 受体和/或 M4 受体的激动剂，可用于治疗毒蕈碱 M1/M4 受体介导的疾病。本发明还提供了含有这些化合物的药物组合物以及这些化合物的治疗用途。化合物包括根据式 1 的化合物或其盐，其中 Q、R1、R2、R3 和 R4 如本文所定义。